Evidence for Seawater Retreat With Advent of Meghalayan Era (∼4200 a BP) in a Coastal Harappan Settlement

Abstract The transformation of mature (urbanized) phase of the ancient Indus civilisation between ∼4200 and 3800 years Before Present (yr BP) overlaps with the beginning of the Meghalayan Age (∼4200 ± 100 yr BP). Though exact cause(s) for decline of urbanized Indus phase are not yet clear, researchers continue to debate whether monsoonal dryness was the sole cause or several other regional factors manifested in a compounding manner. Here, we show a regional relative sea level fall in the downstream area of Indus habitation (south‐western Gujarat region) which initiated at 4150 ± 230 and continued up to 3625 ± 200 yr BP. We provide a multi‐proxy (chronological, sedimentological, mineralogical, isotopic and elemental abundance) data set from a well‐dated vertical sediment trench from Lothal (ancient dockyard area of Indus era) to support this inference. Chief proxies used for inferring the relative sea level fall were bulk sediment carbon and sulfur contents along with their stable isotopes (δ13C and δ34S) and foraminiferal assemblage. The conspicuous shifts in majority of proxies hint at a lowering of sea stand at the regional level that likely dried this ancient Harappan dockyard (used for sea trade). Findings of our study possess implications for Holocene climate changes and their plausible impact(s) on Harappan trade and culture. Additionally, it invites evidences for large scale geological changes at ∼4200 yr BP distinct to the Meghalayan era

Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional Study

Increased consumption of unhealthy processed foods, particularly those high in sodium, is a major risk factor for cardiovascular diseases. The nutrition information on packaged foods can help guide consumers toward products with less sodium and support government actions to improve the healthiness of the food supply. The aims of this study were to estimate the proportion of packaged foods displaying nutrition information for sodium and other nutrients specified by Nigerian nutrition labelling regulations and to determine the amount of sodium in packaged foods sold in Nigeria using data from the nutritional information panel. Data were collected from November 2020 to March 2021 from in-store surveys conducted in supermarkets in three states. A total of 7039 products were collected. Overall, 91.5% (n = 6439) provided only partial nutrition information, 7.0% (n = 495) provided no nutritional information, and only 1.5% (n = 105) displayed a nutrient declaration that included all nutrients specified by 2019 Nigerian regulations. Some form of sodium content information was displayed for 86% of all products (n = 6032), of which around 45% (n = 2689) expressed this as ‘salt’ and 59% (n = 3559) expressed this as ‘sodium’, while a small number of food products had both ‘salt’ and ‘sodium’ content (3.6%). Provision of sodium or salt information on the label varied between food categories, ranging from 50% (vitamins and supplements, n = 2/4) to 96% (convenience foods, n = 44/46). Food categories with the highest median sodium content were ‘meat and meat alternatives’ (904 mg/100 g), ‘sauces, dressings, spreads, and dips’ (560 mg/100 g), and ‘snack foods’ (536 mg/100 g), although wide variation was often observed within categories. These findings highlight considerable potential to improve the availability and consistency of nutrition information on packaged products in Nigeria and to introduce further policies to reduce the amount of sodium in the Nigerian food supply

Fixed‐dose combination therapy‐based protocol compared with free pill combination protocol: Results of a cluster randomized trial

Abstract Fixed‐dose combination (FDC) therapy is recommended for hypertension management in Nigeria based on randomized trials at the individual level. This cluster‐randomized trial evaluates effectiveness and safety of a treatment protocol that used two‐drug FDC therapy as the second and third steps for hypertension control compared with a protocol that used free pill combinations. From January 2021 to June 2021, 60 primary healthcare centers in the Federal Capital Territory of Nigeria were randomized to a protocol using FDC therapy as second and third steps compared with a protocol that used the same medications in free pill combination therapy for these steps. Eligible patients were adults (≥18 years) with hypertension. The primary outcome was the odds of a patient being controlled at their last visit between baseline to 6‐month follow‐up in the FDC group compared to the free pill group. 4427 patients (mean [SD] age: 49.0 [12.4] years, 70.5% female) were registered with mean (SD) baseline systolic/diastolic blood pressure 155 (20.6)/96 (13.1) mm Hg. Baseline characteristics of groups were similar. After 6‐months, hypertension control rate improved in the two treatment protocols, but there were no differences between the groups after adjustment (FDC = 53.9% versus free pill combination = 47.9%, cluster‐adjusted p = .29). Adverse events were similarly low (<1%) in both groups. Both protocols improved hypertension control rates at 6‐months in comparison to baseline, though no differences were observed between groups. Further work is needed to determine if upfront FDC therapy is more effective and efficient to improve hypertension control rates

IgG levels of participants who were seronegative to SARS-CoV-2 at baseline and corresponding month 3 and month 6 follow up levels.

*Ptrend = (TIF)</p

IgG levels of participants who were seropositive at baseline and corresponding month 3 and month 6 follow up levels.

*Ptrend = 0.08. (TIF)</p

Distribution of IgG levels at baseline (median = 0.178 ug/mL), month 3 (median = 0.348 ug/mL), and month 6 follow-up (median = 0.591 ug/mL) based on complete case analysis.

Distribution of IgG levels at baseline (median = 0.178 ug/mL), month 3 (median = 0.348 ug/mL), and month 6 follow-up (median = 0.591 ug/mL) based on complete case analysis.</p